# Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)for the Treatment of Myelodysplastic Syndromes (MDS)

> **NCT00413114** · PHASE2 · COMPLETED · sponsor: **Gemin X** · enrollment: 24 (actual)

## Conditions studied

- Myelodysplastic Syndromes

## Interventions

- **DRUG:** Obatoclax mesylate (GX15-070MS)

## Key facts

- **NCT ID:** NCT00413114
- **Lead sponsor:** Gemin X
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2009-02
- **Final completion:** 2009-11
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2013-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00413114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00413114, "Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)for the Treatment of Myelodysplastic Syndromes (MDS)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00413114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*